Location History:
- Reinhausen, DE (2014)
- Goettingen, DE (2022 - 2023)
- Göttingen, DE (2023)
- Gleichen, DE (2015 - 2024)
Company Filing History:
Years Active: 2014-2025
Title: Celebrating the Innovations of Inventor Karl Pflanz
Introduction
Karl Pflanz, an innovative inventor based in Gleichen, Germany, has made significant contributions to the field of biotechnology with a total of 15 patents to his name. His work primarily focuses on enhancing biopharmaceutical applications, showcasing his dedication to advancing technology and improving existing methods.
Latest Patents
Among his most recent inventions is a diatomaceous earth composition characterized by a low endotoxin content. This composition comprises an agglomerated mixture of calcined diatomaceous earth particles and water, maintaining a mass ratio of calcined diatomaceous earth particles to water ranging from 1:1.0 to 1:2.0. Notably, the endotoxin content of this diatomaceous earth composition is equal to or less than 0.5 EU/mL. Pflanz also delineates a method for producing this innovative composition, which is specifically designed for use as a precoat agent in precoat filtration applications within the biopharmaceutical industry.
In addition to this, another noteworthy patent involves a media filtration device and method. This device incorporates a preparation container that houses a dissolvable medium situated between the inflow and outflow. It features a mixing arm that generates a directed jet of solvent, enhancing the efficiency of the filtration process. The design includes a sterile filter and a sterilized filtrate space, ensuring optimal functionality and safety.
Career Highlights
Karl Pflanz is an influential figure at Sartorius Stedim Biotech GmbH, where his expertise in biotechnology is leveraged to drive innovation. His work has not only contributed to his company’s advancements but has also paved the way for improved biopharmaceutical processes.
Collaborations
Throughout his career, Pflanz has collaborated with esteemed colleagues, including Sebastian Pruehl and Andreas Graus. Together, they share insights and expertise, further enriching the field of biotechnology and enhancing their innovative potential.
Conclusion
Karl Pflanz’s contributions to the field of biotechnology reflect his commitment to innovation and excellence. His latest patents demonstrate his ability to address critical challenges in biopharmaceutical applications, positioning him as a key inventor in his domain. As he continues to push the boundaries of technology, his work remains vital to the advancement of industry practices.